XML 88 R49.htm IDEA: XBRL DOCUMENT
v3.25.1

Loss per Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Loss per Share |
Schedule of anti-dilutive common equivalent shares | ​
​ | ​ | ​ | ​ | ​
​ | ​ | For the year ended | ​ | For the year ended
​ | ​ | December 31, | ​ | December 31,
​ |  | 2024 |  | 2023
Outstanding options to purchase common shares | ​ | 27,885,450 | ​ | 24,858,162
Outstanding RSUs |  | 34,312,655 |  | 12,484,880
Outstanding shares under ESPP | ​ | 1,882 | ​ | 8,802
Outstanding warrants |  | 38,180,770 |  | 28,480,770
Outstanding Special Shares and options to purchase Special Shares |  | 136,239,964 |  | 136,239,964
Total anti-dilutive common equivalent shares |  | 236,620,721 |  | 202,072,578
​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration